Clinical Trial Update: Safety Study of Oxycodone Hydrochloride and Naltrexone Hydrochloride Extended-Release Capsules in Subjects With Moderate to Severe Chronic Noncancer Pain [Phase 3]

View source ↗

Summary

Phase 3 safety study of oxycodone hydrochloride and naltrexone hydrochloride extended-release capsules in adults with chronic noncancer pain has completed and p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Noncancer Pain

Drugs mentioned

• Oxycodone hydrochloride and naltrexone hydrochloride extended-release capsules (oxycodone hydrochloride and naltrexone hydrochloride extended-release)

Snippet

Sponsor: Pfizer | Conditions: Chronic Noncancer Pain | Phase 3 | Status: COMPLETED | Results posted: 2016-11-21